U.S. Stock News

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Readers hoping to buy T-Mobile US, Inc. ( NASDAQ:TMUS ) for its dividend will need to make their move shortly, as the...

Despite the fact that Chaince Digital Holdings Inc.'s (NASDAQ:CD) value has dropped 11% in the last week insiders who...

Ross Stores, Inc. ( NASDAQ:ROST ) just released its quarterly report and things are looking bullish. Ross Stores beat...

In May 2026, TMC the metals company reported a first-quarter 2026 net loss of US$20.6 million, broadly in line with the prior year, while also slightly improving its basic and diluted loss per share from continuing operations to US$0.05. A few days earlier, Allseas announced signing an agreement with TMC to develop, commission and operate what is expected to be the world’s first commercial-scale polymetallic nodule collection system in the Clarion Clipperton Zone, a move that could be...

LuxExperience B.V (LUXE) drew fresh attention after reporting third quarter and nine month results that paired higher sales with a wider net loss, while also closing the sale of THE OUTNET and outlining a YNAP transformation plan. See our latest analysis for LuxExperience B.V. The latest quarter, with higher sales but a wider loss and fresh restructuring charges, has coincided with pressure on the stock, which is down 21.31% on a 1 month share price basis and 22.53% on a 1 year total...

In May 2026, Enhanced, an elite sports competition and consumer products company, announced a content and distribution partnership with Rumble to stream the inaugural Enhanced Games from Las Vegas and future events, while also leveraging Rumble’s Advertising Center to promote its Live Enhanced platform. This deal gives Rumble another live-sports style content vertical and a targeted advertising client that aims to improve customer acquisition efficiency using its platform. Next, we’ll...

Earlier in May 2026, VEON Ltd. reported first-quarter 2026 results showing revenue of US$1,201 million versus US$1,026 million a year earlier, with net income steady at US$99 million and basic and diluted earnings per share from continuing operations unchanged at US$1.5. Alongside raising its 2026 revenue growth guidance, launching a US$100 million share buyback, and issuing US$1.4 billion of new bonds to refinance existing debt, VEON highlighted rapidly expanding digital revenues and...

Why Ryder System (R) is on investors’ radar today Ryder System (R) has drawn attention after a recent move in its share price, with the stock closing at US$244 and showing mixed short term returns that contrast with its longer term performance. See our latest analysis for Ryder System. The recent 2.33% 1 day share price return and 5.67% 7 day share price return come after a softer 30 day share price move. However, Ryder System’s 66.53% 1 year total shareholder return and 226.92% 3 year total...

Karman Holdings (KRMN) is drawing investor attention after recent trading left the stock down about 9% over the past month and about 21% over the past 3 months, despite a 1 year total return above 50%. See our latest analysis for Karman Holdings. The recent share price return shows momentum fading near the latest price of US$64.10, with the stock down over the past quarter even as the 1 year total shareholder return remains strongly positive. If Karman’s moves in space and defense have caught...

Earnings beat, dividend increase and new protein snacks put PepsiCo (PEP) in focus PepsiCo (PEP) has been back in the spotlight after beating recent earnings expectations, reaffirming full year guidance, raising its dividend for the 54th straight year, and rolling out new protein focused snacks and health oriented drinks. See our latest analysis for PepsiCo. PepsiCo’s recent product launches and dividend increase have come alongside mixed price action, with a 1-day share price return of 1.16%...

AbCellera Biologics (ABCL) is back on investors’ radar after early Phase 1 data for its lead program ABCL635 and a fresh quarterly earnings report that shows higher revenue and a smaller net loss. See our latest analysis for AbCellera Biologics. The recent Phase 1 data for ABCL635 and the quarterly update appear to have coincided with a sharp acceleration in momentum, with the stock showing a 27.14% 7 day share price return, a 71.62% 90 day share price return, and a 163.96% 1 year total...

Earlier in May 2026, Nvidia invested US$10.40 million in Generate Biomedicines, an AI-driven biotech now advancing several drug candidates through clinical development, including a Phase 3 severe asthma program and oncology therapies with FDA Fast Track status. This combination of external validation from a major AI leader and visible clinical momentum underscores how AI-enabled drug discovery is moving from concept toward real-world testing. Next, we’ll examine how Nvidia’s investment and...

Bullish recently reported first-quarter 2026 results showing US$20.01 million in sales and a net loss of US$581.71 million, while also announcing a US$4.20 billion acquisition of Equiniti and facing widening per-share losses versus a year earlier. Amid these developments and broader digital asset volatility, ARK Invest and other institutional investors have been actively building positions in Bullish, signaling renewed institutional focus on its role in tokenization and crypto-market...

Ambiq Micro stock: quick context on recent performance Ambiq Micro (AMBQ) has been drawing attention after sharp recent gains, with the stock up 130% over the past month and up about 172% over the past 3 months. That move comes as investors weigh a US$1.75b market value against the company’s US$81.8m in revenue and a reported net loss of US$38.3m from its ultra low power semiconductor business. See our latest analysis for Ambiq Micro. At a share price of US$81.67, Ambiq Micro’s recent surge,...

Intellia Therapeutics (NTLA) recently reported first quarter results showing a net loss of US$96.23 million and basic loss per share of US$0.81, compared with US$114.33 million and US$1.10 a year earlier. See our latest analysis for Intellia Therapeutics. Despite a recent 7 day share price return that declined 7.83% and a 30 day share price return that declined 7.56%, Intellia’s year to date share price return of 36.81% and 1 year total shareholder return of 37.55% suggest momentum has been...

In the first quarter ended March 28, 2026, Netlist, Inc. reported sales of US$104.89 million, up from US$28.98 million a year earlier, and turned a prior net loss of US$9.49 million into net income of US$8.65 million. This shift from loss to profit, alongside higher basic and diluted earnings per share of US$0.03 from continuing operations, highlights a sharp improvement in Netlist’s operating performance over the past year. With this earnings turnaround as a backdrop, we’ll now examine how...

Earlier this week, Columbia Sportswear’s shares reacted to easing Treasury yields and progress in Iran peace talks, as lower rate expectations and reduced inflation concerns supported companies tied to discretionary consumer spending. Valuation metrics now suggest a sizeable margin of safety alongside a strong overall GF Score™, even as insider activity has been limited to modest selling in recent months. We’ll now examine how cooling Treasury yields and the market’s renewed risk appetite...

UGI (UGI) has just completed a US$500 million fixed income offering, issuing 6.875% senior notes due 2031 under Regulation S and Rule 144A. This move puts its capital structure in focus for shareholders. See our latest analysis for UGI. UGI's US$500 million note issue comes as the stock trades at US$35.65, with the share price down 5.3% year to date but supported by a 2.97% one year total shareholder return and a strong 47.65% three year total shareholder return. This suggests that recent...

Ultra Clean Holdings (UCTT) is back on investor radars after a surge in analyst optimism, with Wall Street raising earnings per share estimates and awarding the stock a top Zacks Rank #1 rating. See our latest analysis for Ultra Clean Holdings. The stock’s share price return has been strong over longer periods, with a 90 day share price return of 36.8% and a year to date share price return of 207.5%. The 1 year total shareholder return sits at 321.53%, suggesting momentum that aligns with the...

Recent performance of Permian Basin Royalty Trust (PBT) Permian Basin Royalty Trust (PBT) has drawn fresh attention after a strong stretch for the stock, with returns of 3.4% over the past day, 6.9% over the past week, and 39.4% over the past month. See our latest analysis for Permian Basin Royalty Trust. Set against a 1 year total shareholder return of 181% and a 5 year total shareholder return of roughly 8x, the recent 30 day share price return of 39.4% and year to date share price return...

In May 2026, Diodes Incorporated reported strong first-quarter results, drew positive analyst commentary on its cyclical recovery, and expanded its AH371xQ automotive-compliant Hall effect latch series for low-threshold motor control and position-sensing applications across a wide range of vehicle systems. This combination of earnings momentum and deeper penetration into automotive electronics underscores how Diodes is increasingly tying its product roadmap to long-term content growth in...

Sigma Lithium Corporation reported first-quarter 2026 results with sales of US$42.34 million versus US$47.67 million a year earlier, while net income rose to US$11.13 million from US$4.73 million. Soon after, investor attention shifted to a Brazilian court order requiring the company’s subsidiary to post collateral over alleged environmental damages, bringing legal, financial, and reputational risks into sharper focus. We’ll now examine how the Brazilian court-ordered collateral for alleged...

In mid-May 2026, Encompass Health Corp. completed a US$500,000,000 private offering of 5.875% senior unsecured notes due 2034 and moved to redeem US$400,000,000 of its 4.500% senior notes due 2028 at par, expecting a US$3,200,000 loss on early extinguishment of debt. This refinancing, alongside plans for a new 50-bed inpatient rehabilitation hospital in Post Falls, Idaho opening in 2028, reshapes the company’s capital structure while supporting continued expansion of its rehabilitation...